Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2020-07-01 Board/Management Inform…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
Bioventix Plc - Appointment of CFO
Board/Management Information Classification · 100% confidence The document is a press release announcing that Bruce Hiscock will join the Board as Chief Financial Officer with immediate effect. It includes required disclosure information under Schedule 2(g) of the AIM Rules for Companies regarding his directorships. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of Board/Management Information (MANG). The document is short and is a direct announcement, not a comprehensive report.
2020-07-01 English
Bioventix Plc - Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is titled 'Bioventix Plc - Director/PDMR Shareholding' and details transactions (sale and option exercise) conducted by Peter Harrison, the Chief Executive Officer (a Person Discharging Managerial Responsibilities or PDMR). This type of mandatory disclosure regarding insider trading or executive share dealings directly corresponds to the definition of Director's Dealing reports. The specific structure and content align perfectly with the requirements for reporting insider transactions, which maps to the 'Director's Dealing' category.
2020-04-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document text is very short (1495 characters) and contains the header 'RNS Number : 0884I' and mentions that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a type of immediate market announcement. Since it is a general regulatory announcement disseminated via the RNS system and does not fit into specific categories like ER, 10-K, or DIV, it falls best under the general Regulatory Filings category (RNS).
2020-03-30 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1478 characters) and contains an 'RNS Number' (0856I), indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for a security, which is a routine operational update related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIV, DIRS, or MANG, the most appropriate fallback category is Regulatory Filings (RNS).
2020-03-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1495 characters) and contains the header 'RNS Number : 0421I' and mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement disseminated via the Regulatory News Service (RNS). Since it is a general regulatory announcement that doesn't fit the specific categories like DIV, ER, or DIRS, and it is an announcement itself rather than a comprehensive report, the most appropriate classification is Regulatory Filings (RNS).
2020-03-30 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1478 characters) and contains an 'RNS Number' (0401I), indicating it is a regulatory news service announcement from the London Stock Exchange. The content describes a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIV, DIRS, or MANG, the most appropriate fallback category is Regulatory Filings (RNS).
2020-03-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.